Since May 1994 she is in complete clinical and molecular remission as demonstrated by absence of M protein, normalization of BM, and quantitative allele-specific oligonucleotide (ASO)-PCR 6 (sensitivity to detect 1 tumor of 1 ϫ 10 5 normal cells). Molecular remission was demonstrated in 8 subsequent BM aspirates.
The second patient (stage IIIA, IgG ) presented with bone pain and diplopia. His BM showed a 99% infiltration, labeling index 3%, and ␤ 2 -microglobulin level of 5 mg/mL. The liquor was infiltrated with plasmablastic cells. He achieved a PR after induction with intermediate-dose melphalan 7 but relapsed just before allogeneic (allo)-BMT. In the liquor a persistent M protein of 1 g/L was found after treatment with methotrexate and cytarabine intrathecally. Evaluation 6 months after transplantation showed a complete clinical remission. Residual myeloma cells however could be detected by quantitative ASO-PCR until 36 months after transplantation ( Figure 1 ). Double-color FISH was performed on thawed cytocentrifuged BM cells, which had been prepared from diagnostic samples and had been stored at Ϫ20°C. A del13 was found in 99 of 100 myeloma cells of patient 1 and in 35 of 100 myeloma cells of patient 2.
The 2 patient histories demonstrate that alloreactivity may overcome the prognostic unfavorable impact of del13 in myeloma. The first patient is in molecular remission more than 10 years after allo-BMT and 8 years after DLIs. The second patient presented with a combination of adverse prognostic factors including a high ␤ 2 -microglobulin level, high labeling index, and meningeal infiltration. He received a transplant in relapse after a very short period of remission. Remarkable, quantitative PCR became negative not until 3 years after transplantation.
Our results suggest that in patients with del13 a search for an HLA-identical family or unrelated donor is justified. The promising results of nonmyeloablative allo-SCT in MM 8,9 justify inclusion of patients in such protocols as soon as unfavorable factors are identified after diagnosis. To the editor:
Not every polymorphism close to the AUG codon can be explained by invoking context effects on initiation of translation
The Ϫ1CϾT change in the annexin V gene, which reduces the risk of myocardial infarction, 1 cannot be explained as simply as your editorial note suggests. 2 The demonstration by Gonzalez-Conejero et al 1 that Ϫ1T increases the efficiency of translation might be correct (the fourth paragraph of this letter discusses some concerns about the in vitro translation assay), but if so, the effect would not be explicable by invoking the Kozak context rules. The rules predict the opposite of what was seen; that is, translation should be more efficient with C rather than T in position Ϫ1, if that position scores at all.
GCCRCCaugG (R ϭ purine) is the optimal context for recognition of the start codon in mammals. Within this motif, some positions are more important than others. Mutagenesis experiments with laboratory constructs showed that A or G in position Ϫ3 (3 nt upstream from the AUG codon, which is numbered ϩ1 to ϩ3) and G in position ϩ4 make the strongest contributions. 3, 4 Only in the absence of Ϫ3R and ϩ4G do mutations in positions Ϫ1 and Ϫ2 score strongly. 3 Inasmuch as the annexin V start site conforms to the consensus motif in positions Ϫ3 and ϩ4, the identity of the base in position Ϫ1 would be expected to affect translation only slightly, if at all.
The context rules, initially established by studying translation in cultured cells, 3, 5 can be replicated using in vitro translation systems, but the experiments must be designed carefully. Reaction conditions, such as the concentration of magnesium, 4, 6 can profoundly affect whether recognition of the AUG codon in vitro displays the same sensitivity to context as is seen in vivo. The coupled transcription/translation system used by many investigators, including Gonzalez-Conejero et al, 1 makes it difficult to adjust magnesium levels and to be sure that exactly the same amount of mRNA is generated from each allele. A small change in translational efficiency is believable when the reduction in initiation from the first AUG codon is accompanied by an increase in initiation from the next AUG downstream (eg, Figure 1 in Kozak 7 ) or when an assay is used that directly monitors the initiation step. 4 One cannot be as confident, however, about a small (1.4-fold) difference in translational efficiency based on measurement of proteins precipitable by trichloroacetic acid. 1 In addition to these practical complications in testing for context effects, there are theoretical limitations. Because secondary structure downstream from the AUG codon can compensate for a less than perfect context, 8 not every mutation within the consensus motif will score.
In some human and mouse genes, a mutation or polymorphism close to the AUG codon, usually in position Ϫ3 or ϩ4, has been shown to reduce translational efficiency, with pathological consequences. 9 Only one previous example involves a change in position Ϫ1: in a patient with ataxia with vitamin E deficiency, a CϾT mutation in the alpha-tocopherol transfer protein gene causes a 2-fold decrease in translation, measured in vivo. 10 In addition to these pathologies linked to mutations in the consensus motif, there is a growing list of human diseases wherein translation of a critical regulatory gene is perturbed by restructuring the 5Ј UTR in ways that add or remove upstream AUG codons. 9,11 Thus, the scanning mechanism for initiation of translation does provide a framework for understanding how some mutations cause disease.
It is possible that the demonstrated increase in plasma levels of annexin V protein associated with the Ϫ1T allele 1 reflects an effect on mRNA stability or splicing. If followup studies rule out these alternative explanations and confirm that the Ϫ1T allele indeed augments translation, the reason could conceivably involve an effect on mRNA secondary structure. I do not think this particular polymorphism can be explained by invoking conventional context effects on AUG codon recognition.
